Sign in

CIK 0000730272 · Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
042729386
Phone
7814499560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
  1. SC 13G/A Stake Amended Statement of Ownership
  2. 10-Q Report Quarterly Report
  3. DEF 14A Proxy Proxy Statement
  4. PRE 14A Proxy Proxy Statement (Preliminary)
  5. POS AM Other Post-effective Amendment for Registration Statement
  6. 10-K Report Annual Report
  7. S-3/A Offering Registration Statement
  8. S-3/A Offering Registration Statement
  9. 8-K/A Event Item 2 · Item 7
  10. SC 13G Stake Amended Statement of Ownership
  11. SC 13D/A Stake Beneficial Ownership Report
  12. S-3 Offering Registration Statement
  13. 8-K Event Item 5 · Item 7
  14. S-3/A Offering Registration Statement
  15. S-3 Offering Registration Statement
  16. 8-K Event Item 2 · Item 7
  17. SC 13G/A Stake Amended Statement of Ownership
  18. 10-Q Report Quarterly Report
  19. 10-Q Report Quarterly Report
  20. SC 13D Stake Beneficial Ownership Report

Page 67 of 69 · 1,379 filings